Which prostate cancer patients are suitable for endocrine therapy

Prostate cancer is generally an androgen-related disease, a lesion of the prostate caused by excessive secretion of androgen. Therefore, endocrine therapy is suitable for all prostate cancer patients, including early prostate cancer patients after surgery, or mid- and late-stage patients before and after radiotherapy and chemotherapy, or late-stage patients who have no chance of treatment. Simple endocrine therapy can also inhibit tumor recurrence to a certain extent, inhibit further tumor progression, prolong the patient's life, and improve the patient's quality of life. Therefore, endocrine therapy can be said to be a better method for treating prostate cancer. If you follow the doctor's advice, regular treatment, and persist in treatment, and control the pSA value in a very low range, it can effectively inhibit the progression of tumor cells and prolong the patient's life.

Among them, endocrine drug therapy plays an important role in the treatment of prostate cancer. Common reactions include: causing sexual disturbances in patients. Endocrine therapy is a treatment method for prostate cancer. It is mainly suitable for patients with advanced prostate cancer or those who cannot tolerate radical prostatectomy.

Medication for enlarged prostate

Clinically, patients with prostate hyperplasia often use 5α-reductase inhibitors and α-receptor blockers to treat prostate hyperplasia. 5α-reductase inhibitors prevent testosterone from converting into dihydrotestosterone. This change in understanding requires us to actively participate in the diagnosis and treatment of prostate enlargement, especially the treatment of patients with high-risk factors for progression. Prostate hypertrophy is also called prostate hyperplasia. Commonly used drugs in clinical practice are divided into the following categories: α-receptor blockers.

How to treat prostate hyperplasia with calcification

Prostatic hyperplasia with calcification is a common disease in middle-aged and elderly male patients. We say that the patient has been confirmed to have prostatic hyperplasia with calcification through color Doppler ultrasound. At the same time, blood PSA examination and ultrasound measurement of residual urine should be completed. A comprehensive treatment plan should be formulated according to the patient's symptoms and test results. With the development of society, people are paying more and more attention to how to reduce large amounts of bleeding and other harm to the human body as much as possible while treating the disease. Minimally invasive technology came into being under this situation. The characteristic of traumatic surgery is to use advanced equipment and superb technology to achieve the same therapeutic effect as conventional surgery with the smallest incision. After elderly men suffer from prostatic hyperplasia, they are prone to symptoms of frequent urination, urgency, pain, and difficulty urinating, and need to be actively treated.